Equi-mRNA: Protein Translation Equivariant Encoding for mRNA Language Models
This work addresses the need for biologically principled mRNA models to improve therapeutic design, representing a novel paradigm rather than an incremental advance.
The paper tackled the problem of modeling synonymous codon usage in mRNA for therapeutic and synthetic biology applications by introducing Equi-mRNA, a codon-level equivariant language model that encodes genetic code symmetries, resulting in up to 10% accuracy improvements in property prediction and up to 4x more realistic sequence generation.
The growing importance of mRNA therapeutics and synthetic biology highlights the need for models that capture the latent structure of synonymous codon (different triplets encoding the same amino acid) usage, which subtly modulates translation efficiency and gene expression. While recent efforts incorporate codon-level inductive biases through auxiliary objectives, they often fall short of explicitly modeling the structured relationships that arise from the genetic code's inherent symmetries. We introduce Equi-mRNA, the first codon-level equivariant mRNA language model that explicitly encodes synonymous codon symmetries as cyclic subgroups of 2D Special Orthogonal matrix (SO(2)). By combining group-theoretic priors with an auxiliary equivariance loss and symmetry-aware pooling, Equi-mRNA learns biologically grounded representations that outperform vanilla baselines across multiple axes. On downstream property-prediction tasks including expression, stability, and riboswitch switching Equi-mRNA delivers up to approximately 10% improvements in accuracy. In sequence generation, it produces mRNA constructs that are up to approximately 4x more realistic under Frechet BioDistance metrics and approximately 28% better preserve functional properties compared to vanilla baseline. Interpretability analyses further reveal that learned codon-rotation distributions recapitulate known GC-content biases and tRNA abundance patterns, offering novel insights into codon usage. Equi-mRNA establishes a new biologically principled paradigm for mRNA modeling, with significant implications for the design of next-generation therapeutics.